Etaluma

Etaluma

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $5.3M

Overview

Etaluma is a private company specializing in innovative, compact fluorescence microscopes that bring live-cell imaging capabilities into standard lab environments like incubators. Its core technology leverages solid-state optics, LED light sources, and CMOS sensors to deliver near-diffraction-limited resolution at a fraction of the cost and size of conventional systems. The company serves the research tools market, primarily in academic and industrial life sciences, with a focus on applications such as cell migration, proliferation, and cytotoxicity assays. Etaluma's business model combines direct sales of its microscopes with OEM partnerships, providing components and customized imaging solutions.

DiagnosticsMedical Devices

Technology Platform

Compact, solid-state inverted fluorescence microscope platform using LED illumination, fixed Chroma filters, and CMOS sensors for high-resolution, zero-pixel-shift live-cell imaging inside incubators.

Funding History

2
Total raised:$5.3M
Series A$5M
Grant$300K

Opportunities

The growing demand for affordable, continuous live-cell imaging in drug discovery and basic research presents a significant mid-market gap.
Expanding OEM partnerships to integrate its technology into larger automated systems or specialized diagnostic platforms offers a scalable growth channel beyond direct sales.

Risk Factors

Intense competition from large, established microscope manufacturers with greater resources and brand power poses a constant threat.
The company's reliance on research capital budgets, which are cyclical and sensitive to economic and funding cycles, creates revenue volatility risk.

Competitive Landscape

Etaluma competes in the mid-range segment against high-cost, feature-rich systems from giants like Zeiss, Leica, Nikon, and Olympus, and against other lower-cost and compact imaging systems from companies like BioTek (part of Agilent) and Molecular Devices. Its differentiation is a unique combination of incubator-compatible compactness, high optical quality, and a price point significantly below traditional research microscopes.